Article
Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation.
Glia - 1 Mar 2016
Ossola Bernardino, Zhao Chao, Compston Alastair, Pluchino Stefano, Franklin Robin J M, Spillantini Maria Grazia
Abstract excerpt
Oligodendrocyte progenitor cell (OPC) differentiation is an important therapeutic target to promote remyelination in multiple sclerosis (MS). We previously reported hyperphosphorylated and aggregated microtubule-associated protein tau in MS lesions, suggesting its involvement in axonal degeneration. However, the influence of pathological tau-induced axonal damage on the potential for remyelination is unknown....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
